Browse result page of B3Pdb

The total number entries retrieved from this search are 137, scroll left/right for detailed information.
B3pdbIDPEPTIDE NAMEPEPTIDE SEQUENCE (1-letter)PEPTIDE SEQUENCE (3-letter)N-TERMINAL MODIFICATIONC-TERMINAL MODIFICATION CHEMICAL MODIFICATIONPEPTIDE LENGTHPEPTIDE CONFORMATIONPEPTIDE NATURESOURCE/ORIGIN OF PEPTIDESMILESCELL LINEIn vitro CONCENTRATIONIn vitro METHODIn vitro RESULTANIMAL MODELIn vivo CONCENTRATIONIn vivo MODE OF DELIVERYIn vivo METHODIn vivo RESULTACTIONTRANSPORT TYPESUBCELLULAR LOCALISATIONCOMBINATIONPHYSICAL CONDITIONRESPONSERESULTLABELPMID
b3pdb_0926OncocinVDKPPYLPRPRPPRRIYNR-NH2Val-Asp-Lys-Pro-Pro-Tyr-Leu-Pro-Arg-Pro-Arg-Pro-Pro-Arg-Arg-Ile-Tyr-Asn-Arg-NH2NANANA19LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.02584 ml/g Direct iodination 24164260
b3pdb_0927Drosocin (unglycosylGKPRPYSPRPTSHPRPIRVGly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAGila monsterNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.217 min-1 Direct iodination 24164260
b3pdb_0928Drosocin (unglycosylGKPRPYSPRPTSHPRPIRVGly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAGila monsterNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 33% Direct iodination 24164260
b3pdb_0929Drosocin (unglycosylGKPRPYSPRPTSHPRPIRVGly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAGila monsterNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 67% Direct iodination 24164260
b3pdb_0930Drosocin (unglycosylGKPRPYSPRPTSHPRPIRVGly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAGila monsterNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00086 mL/(g x min) Direct iodination 24164260
b3pdb_0931Drosocin (unglycosylGKPRPYSPRPTSHPRPIRVGly-Lys-Pro-Arg-Pro-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAGila monsterNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.01962 ml/g Direct iodination 24164260
b3pdb_0932Drosocin Pro5Hyp (unGKPR-Hyp-YSPRPTSHPRPIRGly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAsynthetic,milkweed bugNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant -0.079 min-1 Direct iodination 24164260
b3pdb_0933Drosocin Pro5Hyp (unGKPR-Hyp-YSPRPTSHPRPIRGly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAsynthetic,milkweed bugNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 33% Direct iodination 24164260
b3pdb_0934Drosocin Pro5Hyp (unGKPR-Hyp-YSPRPTSHPRPIRGly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAsynthetic,milkweed bugNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 67% Direct iodination 24164260
b3pdb_0935Drosocin Pro5Hyp (unGKPR-Hyp-YSPRPTSHPRPIRGly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAsynthetic,milkweed bugNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00037 mL/(g x min) Direct iodination 24164260
b3pdb_0936Drosocin Pro5Hyp (unGKPR-Hyp-YSPRPTSHPRPIRGly-Lys-Pro-Arg-4t-Hyp-Tyr-Ser-Pro-Arg-Pro-Thr-Ser-His-Pro-Arg-Pro-Ile-Arg-ValNANANA19LinearNAsynthetic,milkweed bugNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.01957 ml/g Direct iodination 24164260
b3pdb_0964ANG1005(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(brain/perfusate) 0.9333 ml/g H3/C14 18574456
b3pdb_0965ANG1005(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(capillary/perfusate) 0.3111 ml/g H3/C14 18574456
b3pdb_0966ANG1005(2'-N-succinimide-paclitaxel)TFFYGGSRG-(2'-N-succinimide-paclitaxel)KRNNF(2'-N-succinimide-paclitaxel)KTEEY(2'-N-succinimide-paclitaxel)Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-(2'-N-succinimide-paclitaxel)Lys-Arg-Asn-Asn-Phe-(2'-N-succinimide-paclitaxel)Lys-Thr-Glu-Glu-TyrNANANA19LinearNAChemically synthesizedNANANACapillary deplition in situ b pNANANANANANA NA NA NA NA NA CD(parenchyma/perfusate) 0.5037 ml/g H3/C14 18574456
b3pdb_0967Benzylpenicillin-SynBenzylpenicillin-RGGRLSYSRRRFSTSTGRBenzylpenicillin-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-ArgNANANA18LinearNAmouseNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 20% H3/C14 12164379
b3pdb_0968Benzylpenicillin-SynBenzylpenicillin-RGGRLSYSRRRFSTSTGRBenzylpenicillin-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-ArgNANANA18LinearNAmouseNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 80% Direct iodination 12164379
b3pdb_0969Doxorubicin-SynB1Doxorubicin-linker-RGGRLSYSRRRFSTSTGRDoxorubicin-linker-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-ArgNANANA18LinearNAChemically synthesizedNANANANANANANAIn situ perfusion (single time)NANA NA Permeability NA NA NA Unidirectonal influx rate constant 0.0684 mL/(g x min) H3/C14 12164379
b3pdb_0970Doxorubicin-(D)-PeneDoxorubicin-linker-rqikiwfqnrrmkwkkDoxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)LysNA16LinearNAChemically synthesizedNANANANANANANAin situ brain perfusionNANA NA Permeability NA NA NA Volume of donor compartment 0.77764 ml/g H3/C14 11123372
b3pdb_0971Doxorubicin-(D)-PeneDoxorubicin-linker-rqikiwfqnrrmkwkkDoxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)LysNANANA16LinearNAChemically synthesizedNANANANANANANAIn situ perfusion (single time)NANA NA Permeability NA NA NA Unidirectonal influx rate constant 0.072 mL/(g x min) H3/C14 10727512
b3pdb_0980pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.1019 min-1 Direct iodination 26465925
b3pdb_0981pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 19.53% Direct iodination 26465925
b3pdb_0982pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 80.47% Direct iodination 26465925
b3pdb_0983pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00602 mL/(g x min) Direct iodination 26465925
b3pdb_0984pVECLLIILRRRIRKQAHAHSK-NH2Leu-Leu-Ile-Ile-Leu-Arg-Arg-Arg-Ile-Arg-Lys-Gln-Ala-His-Ala-His-Ser-Lys-NH2NANANA18LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.02313 ml/g Direct iodination 26465925
b3pdb_1111BIP-2GLWEDLLYNINRYAHYITGly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-ThrNANANA18LinearNAChemically synthesizedNANANAEfflux study ICUNANANANANANA NA Permeability NA NA NA Brain elemination rate constant 0.06 min-1 Direct iodination 26536593
b3pdb_1112BIP-2GLWEDLLYNINRYAHYITGly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-ThrNANANA18LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % parenchyma 76.90% Direct iodination 26536593
b3pdb_1113BIP-2GLWEDLLYNINRYAHYITGly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-ThrNANANA18LinearNAChemically synthesizedNANANACapillary depletionNANANANANANA NA NA NA NA NA % capillary 23.10% Direct iodination 26536593
b3pdb_1114BIP-2GLWEDLLYNINRYAHYITGly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-ThrNANANA18LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Unidirectional influx rate constant 0.00035 mL/(g x min) Direct iodination 26536593
b3pdb_1115BIP-2GLWEDLLYNINRYAHYITGly-Leu-Trp-Glu-Asp-Leu-Leu-Tyr-Asn-Ile-Asn-Arg-Tyr-Ala-His-Tyr-Ile-ThrNANANA18LinearNAChemically synthesizedNANANANANANANAIntravenous NANA NA Permeability NA NA NA Initial disrobution volume 0.01267 ml/g Direct iodination 26536593
b3pdb_1145gH625HGLASTLTRWAHYNALIRAHis-Gly-Leu-Ala-Ser-Thr-Leu-Thr-Arg-Trp-Ala-His-Tyr-Asn-Ala-Leu-Ile-Arg-AlaNANANA19LinearNAChemically synthesizedNANANAImaging techniques NANANANANANA NA Permeability NA NA NA Brain to plasma ratio 0.09 Fluorescent label 25792823
b3pdb_1176L57TWPKHFDKHTFYSILKLGKHThr-Trp-Pro-Lys-His-Phe-Asp-Lys-His-Thr-Phe-Tyr-Ser-Ile-Leu-Lys-Leu-Gly-Lys-HisNANANA20LinearNAHemoglobinNANANANANANANAIn situ perfusion (single time)NANA NA Permeability NA NA NA % injected dose 0.22 %/g Direct iodination 29090274
b3pdb_1177L57TWPKHFDKHTFYSILKLGKHThr-Trp-Pro-Lys-His-Phe-Asp-Lys-His-Thr-Phe-Tyr-Ser-Ile-Leu-Lys-Leu-Gly-Lys-HisNANANA20LinearNAHemoglobinNANANANANANANAIntravenous NANA NA Permeability NA NA NA % injected dose 0.042 %/g Direct iodination 29090274
b3pdb_1190Macrocyclic inhibitocGflGGrrrGfGGIGGcCys-Gly-Phe-Leu-Gly-Gly-Arg-Arg-Arg-Gly-Phe-Gly-Gly-Ile-Gly-Gly-CysNANANA17LinearNAChemically synthesizedNANANAInitial concentration in donor chamber-CultureNANANANANANA NA Permeability NA NA NA Parallel artificial membrane permeation assay apparent permiability cofficient 14.6 cm/s Fluorescent label 29908130
b3pdb_1208Adiponetic peptideLQVYGDGDHNGLYADNVNNANANANA18LinearNANANANANANANAC57BL/6J mice15 mg/kg of APNpIntraperitonealFourier Transform Infrared SpectroscopyAPNp suppressed mitochondrial and ATF4-CHOP apoptosis pathways in a Smad3 dependent manner. NA Permeability NA Alone ICH injury in diabetic mice NA APNp promoted neural sur- vival following ICH injury in the diabetic setting, by suppressing mitocho NA 31922310
b3pdb_1209PenetratinRQIKIWFQNRRMKWKKNANANANA16LinearNAChemically synthesizedNANANANANAMale Sprague-Dawley rats2.0 mMIntranasalELISAL-penetratin increased the systemic absorption of leptin after intranasal administration. The intranasal coadministration with L-penetratin could deliver leptin to the brain and in particula Permeability Hypothalamus Combined with leptin Obesity NA The intranasal coadministration with L-penetratin has a potential to deliver leptin into the therape NA 31926192
b3pdb_1223D-penetratinRQIKIWFQNRRMKWKKNANANANA16NANAChemically synthesizedNAIn situ brain perfusion techniqueNACapillary depletion methodVectorization of dox led to a 20-fold increase in the amount of dox transportation.Male Sprague-Dawley rats2.5 mg/kgIntravenous Capillary depletion methodIt led to a significant increase in brain dox concentrations during the first 30 min of postadminist The use of these peptide vectors for brain delivery of dox. Transcytosis Brain parenchyma Combined with Doxorubicin NA NA NA NA 10727512
b3pdb_1224SynB1RGGRLSYSRRRFSTSTGRNANANANA18NANAChemically synthesizedNAIn situ brain perfusion techniqueNACapillary depletion methodVectorization of dox led to a 20-fold increase in the amount of dox transportation.Male Sprague-Dawley rats2.5 mg/kgIntravenous Capillary depletion methodIt led to a significant increase in brain dox concentrations during the first 30 min of postadminist The use of these peptide vectors for brain delivery of dox. Transcytosis Brain parenchyma Combined with Doxorubicin NA NA NA NA 10727512